CD34+VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 3, 2014, Pages 422-433

  Tan, Yu zhen ^a   Wang, Hai jie ^a   Zhang, Mei hua ^a,b   Quan, Zhe ^a   Li, Ting ^a   He, Qi zhi ^a,c  

^a FUDAN UNIVERSITY   (China)

^b Shandong Provincial Key Laboratory for Improving Birth Outcome Technique   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Differentiation; Endothelial progenitor cells; Lymphangiogenesis; VEGF C; VEGFR 3

Indexed keywords

CD34 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GEL; MESSENGER RNA; SMALL INTERFERING RNA; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ANIMAL; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CELL SEPARATION; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; FLOW CYTOMETRY; GEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; RAT; STEM CELL; ULTRASTRUCTURE;

ANIMALS; ANTIGENS, CD34; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; GELS; GENE EXPRESSION REGULATION; HUMANS; RATS; RNA, MESSENGER; RNA, SMALL INTERFERING; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84894563459     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12233     Document Type: Article

References (54)

1. Schulte-Merker S, Sabine A, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol. 2011; 193: 607-18.
2. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hualuronan. J Cell Biol. 1999; 144: 789-801.
3. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999; 154: 385-94.
4. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA. 1995; 92: 3566-70.
5. Wigle JT, Oliver G. Prox-1 function is required for the development of the murine lymphatic system. Cell. 1999; 98: 769-78.
6. Schmid-Schönbein GW. Microlymphatics and lymph flow. Physiol Res. 1990; 70: 987-1028.
7. Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc Res Techniq. 2001; 55: 92-9.
8. Witte MH, Jones K, Wilting J, et al. Structure function relationships in the lymphatic system and implications for cancer biology. Cancer Metast Rev. 2006; 25: 159-84.
9. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005; 438: 946-53.
10. McCarter MD, Clarke JH, Harken AH. Lymphangiogenesis is pivotal to the trials of a successful cancer metastasis. Surgery. 2004; 135: 121-4.
11. Achen MG, Stacker SA. Molecular control of lymphatic metastasis. Ann NY Acad Sci. 2008; 1131: 225-34.
12. Tan Y. Basic fibroblast growth factor-mediated lymphangiogenesis of lymphatic endothelial cells isolated from dog thoracic ducts: effects of heparin. Jap J Physiol. 1998; 42: 133-41.
13. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008; 28: 1584-95.
14. Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med. 2005; 56: 79-101.
15. + lymphatic/vascular endothelial precursor cells. Blood. 2003; 101: 168-72.
16. + progenitors share phenotypic, functional and gene expression profile similarities with lymphatics. J Cell Mol Med. 2009; 13: 522-34.
17. Religa P, Cao R, Bjorndahl M, et al. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood. 2005; 106: 4184-90.
18. Kerjaschki D, Huttary N, Raab I, et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med. 2006; 12: 230-4.
19. Wu JH, Wang HJ, Tan YZ, et al. Characterization of rat very small embryonic-like stem cells and cardiac repair after cell transplantation for myocardial infarction. Stem Cells Dev. 2012; 21: 1367-79.
20. Wang HJ, Zhang D, Tan YZ, et al. Autophagy in endothelial progenitor cells is cytoprotective in hypoxic conditions. Am J Physiol Cell Physiol. 2013; 304: C617-26.
21. Guo HD, Wang HJ, Tan YZ, et al. Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction. Tissue Eng Part A. 2011; 17: 45-58.
22. Kato S. Organ specificity of the structural organization and fine distribution of lymphatic capillary networks: histochemical study. Histol Histopathol. 2000; 15: 185-97.
23. Zhang DY, Wang HJ, Tan YZ. Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway. PLoS ONE. 2011; 6: e21397.
24. Tan YZ, Zhao Y, Wang HJ, et al. Effects of vascular endothelial growth factor on angiogenesis of the endothelial cells isolated from cavernous malformations. Chin Sci Bull. 2008; 53: 370-6.
25. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-7.
26. + cells identifies a population of functional endothelial precursors. Blood. 2000; 95: 952-8.
27. Mund JA, Case J. The ontogeny of endothelial progenitor cells through flow cytometry. Curr Opin Hematol. 2011; 18: 166-70.
28. Prokopi M, Mayr M. Proteomics: a reality-check for putative stem cells. Circ Res. 2011; 108: 499-511.
29. Jiang S, Bailey AS, Goldman DC, et al. Hematopoietic stem cells contribute to lymphatic endothelium. PLoS ONE. 2008; 3: e3812.
30. Sauter B, Foedinger D, Sterniczky B, et al. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells: differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem. 1998; 46: 165-76.
31. Chen L, Hamrah P, Cursiefen C, et al. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med. 2004; 10: 813-5.
32. Schoppmann SF, Birner P, Stöckl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002; 161: 947-56.
33. Lavergne M, Vanneaux V, Delmau C, et al. Cord blood-circulating endothelial progenitors for treatment of vascular diseases. Cell Proliferat. 2011; 44: 44-7.
34. + progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS ONE. 2010; 5: e9173.
35. Paprocka M, Krawczenko A, Dus D, et al. CD133 positive progenitor endothelial cell lines from human cord blood. Cytometry Part A. 2011; 79: 594-602.
36. Murohara T. Cord blood-derived early outgrowth endothelial progenitor cells. Microvasc Res. 2010; 79: 174-7.
37. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004; 104: 2752-60.
38. Karkkainen MJ, Haiko P, Sainio K, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004; 5: 74-80.
39. Kono T, Kubo H, Shimazu C, et al. Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cells. Arterioscler Thromb Vasc Biol. 2006; 26: 2070-6.
40. Kreuger J, Nilsson I, Kerjaschki D, et al. Early lymph vessel development from embryonic stem cells. Arterioscler Thromb Vasc Biol. 2006; 26: 1073-8.
41. Conrad C, Niess H, Huss R, et al. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation. 2009; 119: 281-9.
42. Suzuki H, Watabe T, Kato M, et al. Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells. Blood. 2005; 105: 2372-9.
43. Dumont DJ, Jussila L, Taipale J, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 1998; 282: 946-9.
44. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-7.
45. Pepper MS, Tille JC, Nisato R, et al. Lymphangiogenesis and tumor metastasis. Cell Tissue Res. 2003; 314: 167-77.
46. Schoppmann SF, Fenzl A, Nagy K, et al. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery. 2006; 139: 839-46.
47. Baluk P, Tammela T, Ator E, et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest. 2005; 115: 247-57.
48. Karpanen T, Egeblad M, Karkkainen MJ, et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 2001; 61: 1786-90.
49. Bogos K, Renyi-Vamos F, Dobos J, et al. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Clin Cancer Res. 2009; 15: 1741-6.
50. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011; 473: 298-307.
51. Foresta C, De Toni L, Ferlin A, et al. Clinical implication of endothelial progenitor cells. Expert Rev Mol Diagn. 2010; 10: 89-105.
52. He Y, Rajantie I, Ilmonen M, et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res. 2004; 64: 3737-40.
53. Eichten A, Hyun WC, Coussens LM. Distinctive features of angiogenesis and lymphangiogenesis determine their functionality during de novo tumor development. Cancer Res. 2007; 67: 5211-20.
54. Padera TP, Stoll BR, Tooredman JB, et al. Cancer cells compress intratumour vessels. Nature. 2004; 427: 695.